If you’ve been on TikTok or any other social media — or any kind of media, for that matter — you’ve probably come across ...

The supply of GLP-1 drugs for weight loss and diabetes treatment is expected to tighten this week with a federal deadline to halt the sale and production of off-brand products that many patients in ...

Above all, Burke said "the most disappointing part" is when she sees people say they "miss the old Cheryl" and reference her ...

In an abrupt and surprising twist, the CEO of Ozempic-maker Novo Nordisk has been ousted from his position as the head of the company. The Danish pharmaceutical giant announced Friday that ...

Ozempic and Wegovy maker Novo Nordisk ousted CEO Lars Fruergaard Jorgensen on Friday over concerns the company is losing its first-mover advantage in the highly competitive obesity drug market.

May 16 (Reuters) - Ozempic-maker Novo Nordisk (NOVOb.CO), opens new tab on Friday ousted its CEO Lars Fruergaard Jorgensen over concerns the company is losing its first-mover advantage in the ...

(Reuters) -Ozempic-maker Novo Nordisk on Friday ousted its CEO Lars Fruergaard Jorgensen over concerns the company is losing its first-mover advantage in the competitive obesity drug market to ...

Lars Fruergaard Jørgensen said he was “surprised” that the Ozempic-maker’s largest shareholder, the Novo Nordisk Foundation, had decided to remove him. “I did not see this coming,” he ...

The boss of Ozempic maker Novo Nordisk lost his job yesterday after its share price plunged amid intensifying competition in the multi-billion pound fat jab market. Lars Fruergaard Jorgensen is ...

Even doctors are baffled by her inability to regain weight, months after she stopped using Ozempic. “They can’t figure it out,” she said. “But I think it’s just because I’m getting ...

In a compelling discussion titled “The Trojan Horse of Indian Healthcare”, panellists Dr. Anoop Misra, Dr. Preetha Reddy, and Dr. Chandrakant Lahariya tackle the growing burden of non ...